![](/img/cover-not-exists.png)
Pharmacological and clinical aspects of fluvoxamine (Depromel), the first selective serotonin reuptake inhibitor approved for clinical use employed in Japan.
HACHISU, Mitsugu, ICHIMARU, YasuyukiVolume:
115
Year:
2000
Journal:
Folia Pharmacologica Japonica
DOI:
10.1254/fpj.115.271
File:
PDF, 722 KB
2000